Last updated: June 20, 2024
Sponsor: Instituto de Cardiologia do Rio Grande do Sul
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autonomic Nervous System
Treatment
IMT PowerBreath Placebo
CardioBreathApp
IMT PowerBreath
Clinical Study ID
NCT03672760
Cardiology
Ages 45-65 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Follicle Stimulating Hormone (FSH)>35mui/ml
minimum 12 months amenorrhea
sedentary life style (less than 150 minutes per week of exercise)
Exclusion
Exclusion Criteria:
Hypertension
Diabetes
Obesity
Use of Betablockers
recent cardiovascular events or surgery
renal alterations
respiratory and/or motor pathologies
smoking
BMI>29,9
Study Design
Total Participants: 24
Treatment Group(s): 3
Primary Treatment: IMT PowerBreath Placebo
Phase:
Study Start date:
September 01, 2023
Estimated Completion Date:
July 30, 2025
Study Description
Connect with a study center
Instituto de Cardiologia do Rio Grande do Sul
Porto Alegre, Rio Grande Do Sul 90620-000
BrazilActive - Recruiting
Cardiology Institute of Rio Grande do Sul
Pôrto Alegre, Rio Grande Do Sul
BrazilSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.